| human | Q5 |
| P496 | ORCID iD | 0000-0002-5128-0693 |
| P106 | occupation | researcher | Q1650915 |
| Q54220029 | A 56-Year-Old Woman With Multiple Pulmonary Cysts and Severe Chest Pain. |
| Q39613401 | A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia |
| Q40072430 | A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey |
| Q43136155 | A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease |
| Q44370746 | A long-lasting idiopathic factor V inhibitor |
| Q53659325 | A phase 1/2 study of bosutinib in Japanese adults with Philadelphia chromosome-positive chronic myeloid leukemia. |
| Q89767641 | A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation |
| Q42201602 | Acquired factor X deficiency associated with atypical AL-amyloidosis |
| Q41154840 | Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes |
| Q61806098 | Association between chronic bacterial airway infection and prognosis of bronchiolitis obliterans syndrome after hematopoietic cell transplantation |
| Q95834151 | Bone turnover markers as an aid to monitor osteoporosis following allogeneic hematopoietic stem cell transplantation |
| Q38071879 | Bortezomib-induced posterior reversible encephalopathy syndrome in a patient with newly diagnosed multiple myeloma |
| Q40973515 | CD25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplant predicts relapse in patients with acute myeloid leukemia without complete remission |
| Q44981825 | Calcineurin-inhibitor pain syndrome following haematopoietic stem cell transplantation |
| Q40399440 | Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia |
| Q40528777 | Central nervous system infection following allogeneic hematopoietic stem cell transplantation. |
| Q43275106 | Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors |
| Q40678595 | Chronic myelogenous leukemia initially presenting with multiple subcutaneous tumors due to extramedullary hematopoiesis |
| Q40644980 | Chronic myeloid leukemia relapsing ten years after allogenic bone marrow transplantation. |
| Q43092618 | Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion |
| Q85775323 | Clinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia |
| Q41017468 | Clinical impact of hematogones on outcomes of allogeneic hematopoietic stem cell transplantation. |
| Q40112657 | Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation. |
| Q83760924 | Clinical impact of pre-transplant pulmonary impairment on survival after allogeneic hematopoietic stem cell transplantation |
| Q54263525 | Clinical impact of underweight status at diagnosis on elderly patients with acute myeloid leukemia: a retrospective study of JALSG GML200. |
| Q42256587 | Clinical outcome of hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL): experience from a single institution |
| Q36828700 | Clinical utility of high-flow nasal cannula oxygen therapy for acute respiratory failure in patients with hematological disease |
| Q110661776 | Comparable Leukemia-Free Survival after Autologous Hematopoietic Cell Transplantation Versus HLA-Identical Sibling Hematopoietic Cell Transplantation for Adult Acute Myeloid Leukemia in First Complete Remission: A Registry Study By the Adult AML Work |
| Q57293458 | Comparison of HLA allele mismatch and antigen mismatch in unrelated bone marrow transplantation in patients with leukemia |
| Q64114551 | Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups |
| Q40561903 | Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation. |
| Q91571580 | Continuous lenalidomide treatment after bortezomib-melphalan-prednisolone therapy for newly diagnosed multiple myeloma |
| Q53349066 | Correlation between survival and number of mobilized CD34+ cells in patients with multiple myeloma or Waldenström macroglobulinemia. |
| Q83097671 | Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation |
| Q46376561 | Cytogenetic abnormalities without evidence of relapse after treatment with imatinib and stem cell transplantation in a patient with Ph-positive ALL. |
| Q57021827 | Cytomegalovirus meningitis in a patient with relapsed acute myeloid leukemia |
| Q54528859 | Delayed hematological recovery following autologous transplantation utilizing peripheral blood stem cells harvested after treatment with arsenic trioxide. |
| Q87119223 | Development of aggressive T-cell leukemia at 1 month after the diagnosis of hypereosinophilic syndrome |
| Q48351302 | Diagnostic open brain biopsy following initial negative results of cerebrospinal fluid assessment for Toxoplasma |
| Q64375155 | Disseminated adenovirus infection in a patient with relapsed refractory multiple myeloma undergoing autologous stem cell transplantation and pomalidomide/dexamethasone as salvage regimens |
| Q50051318 | Disseminated fusariosis in patients with acute leukemia: a retrospective analysis of three cases |
| Q40518943 | Disseminated nocardiosis after unrelated bone marrow transplantation |
| Q93152130 | Distribution of Transplantation-Associated Thrombotic Microangiopathy (TA-TMA) and Comparison between Renal TA-TMA and Intestinal TA-TMA: Autopsy Study |
| Q42286376 | Divergence paralysis caused by acute midbrain infarction |
| Q40414162 | Donor cell leukemia with bone marrow necrosis. |
| Q42203455 | Effect of graft sources on allogeneic hematopoietic stem cell transplantation outcome in adults with chronic myeloid leukemia in the era of tyrosine kinase inhibitors: a Japanese Society of Hematopoietic Cell Transplantation retrospective analysis |
| Q91380537 | Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial |
| Q41756602 | Efficacy and tolerability of Entecavir for hepatitis B virus infection after hematopoietic stem cell transplantation |
| Q33419298 | Efficacy of molecular response at 1 or 3 months after the initiation of dasatinib treatment can predict an improved response to dasatinib in imatinib-resistant or imatinib-intolerant Japanese patients with chronic myelogenous leukemia during the chr |
| Q33392276 | Eight-year follow-up of patients with immune thrombocytopenic purpura related toH. pyloriinfection |
| Q91181045 | Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan |
| Q88466626 | Emergence of Dipstick Proteinuria Predicts Overt Nephropathy in Patients Following Stem Cell Transplantation |
| Q53307978 | Erythrocytosis caused by erythropoietin-producing thymic carcinoma. |
| Q48288218 | Extradural plasmacytoma with central nervous system involvement in newly diagnosed multiple myeloma. |
| Q41994650 | Extramedullary Gastric Relapse at the Time of Bone Marrow Relapse of Acute Lymphoblastic Leukemia after Allogeneic Bone Marrow Transplantation. |
| Q92466880 | Familial case of hereditary Pelger-Huët anomaly |
| Q90912657 | Fatal Neutropenic Enterocolitis Caused by Stenotrophomonas maltophilia: A Rare and Underrecognized Entity |
| Q37376599 | Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. |
| Q59333338 | Fecal microbiota transplantation with frozen capsules for a patient with refractory acute gut graft-versus-host disease |
| Q43416829 | Frequent exacerbation of pulmonary nocardiosis during maintenance antibiotic therapies in a hematopoietic stem cell transplant recipient |
| Q40847122 | Gastric Antral Vascular Ectasia during the Treatment of Chronic Myelogenous Leukemia with Imatinib Mesylate |
| Q85482092 | Gastrointestinal AA amyloidosis following allogeneic hematopoietic stem cell transplant in a patient with chronic myelogenous leukemia |
| Q90678020 | Gene rearrangements of MLL and RUNX1 sporadically occur in normal CD34+ cells under cytokine stimulation |
| Q92544017 | Geriatric nutritional risk index (GNRI) just before allogeneic hematopoietic stem cell transplantation predicts transplant outcomes in patients older than 50 years with acute myeloid leukemia in complete remission |
| Q96307024 | Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation |
| Q81073764 | Granulocyte colony-stimulating factor-primed donor lymphocyte infusion after salvage chemotherapy for treatment of relapsed acute leukemia after allogeneic stem cell transplantation |
| Q39347202 | Gut microbiota and acute graft-versus-host disease |
| Q64074972 | HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome |
| Q53089883 | Harmonization of molecular monitoring of chronic myeloid leukemia therapy in Japan. |
| Q42230123 | Hes1 upregulation contributes to the development of FIP1L1-PDGRA-positive leukemia in blast crisis. |
| Q90459507 | Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation |
| Q61798366 | High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation |
| Q83498227 | High-resolution computed tomography features of pulmonary chronic graft-versus-host disease following hematopoietic stem cell transplantation: histopathological correlation |
| Q92985645 | Hypercalcemia and osteolytic bone lesions as the major symptoms in a chronic lymphocytic leukemia/small lymphocytic lymphoma patient: a rare case |
| Q44012798 | Imatinib mesylate (Gleevec) in the treatment of 2 patients with Philadelphia-positive ALL relapsing after allogeneic stem cell transplantation |
| Q53592851 | Immune-mediated myelopathy following allogeneic stem cell transplantation. |
| Q41221647 | Immunological analysis of a patient with hepatitis B virus (HBV) reactivation after bone marrow transplantation |
| Q41624977 | Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation |
| Q92540556 | Impact of High-Frequency HLA Haplotypes on Clinical Cytomegalovirus Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation |
| Q86242931 | Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and M |
| Q42961857 | Impact of post-transplant imatinib administration on Philadelphia chromosome-positive acute lymphoblastic leukaemia. |
| Q41359251 | Impact of prior azacitidine on the outcome of allogeneic hematopoietic transplantation for myelodysplastic syndrome |
| Q57797263 | Impact of splicing factor mutations on clinical features in patients with myelodysplastic syndromes |
| Q45201961 | Incapacitating lower limb pain syndrome in cord blood stem cell transplant recipients with calcineurin inhibitor |
| Q83921340 | Incidence, risk factors, and clinical outcomes of cataracts following hematopoietic stem cell transplantation |
| Q40152223 | Incidental detection of congenital Robertsonian translocation at diagnosis of Philadelphia chromosome-positive acute lymphocytic leukemia |
| Q91196020 | Increased Relapse Risk of Acute Lymphoid Leukemia in Homozygous HLA-C1 Patients after HLA-Matched Allogeneic Transplantation: A Japanese National Registry Study |
| Q64113816 | Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60-69 years with myelodysplastic syndrome |
| Q40443645 | Influence of Differently Licensed KIR2DL1-Positive Natural Killer Cells in Transplant Recipients with Acute Leukemia: A Japanese National Registry Study |
| Q90614286 | Influence of HLA 1-3-locus mismatch and antithymocyte globulin administration in unrelated bone marrow transplantation |
| Q33383962 | Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation |
| Q44218960 | Kinetics of peripheral hepatitis B virus-specific CD8+ T cells in patients with onset of viral reactivation. |
| Q39720947 | Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation |
| Q89889169 | Late appearance of eosinophilia in myeloid blast phase of myeloid neoplasm with rearrangement of PDGFRβ |
| Q51667473 | Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation. |
| Q39110878 | Long-term follow-up results of a phase I/II study of melphalan, prednisolone and bortezomib in Japanese transplant-ineligible multiple myeloma patients (JPN-102). |
| Q53942216 | Low-dose antithymocyte globulin for treatment of steroid-pulse-resistant acute graft-versus-host disease. |
| Q53664666 | Meningeal hematopoiesis following radiation myelitis in a hematopoietic stem-cell transplant recipient. |
| Q33386791 | Mikulicz's disease with severe thrombocytopenia following autologous stem cell transplantation in a multiple myeloma patient |
| Q90748001 | Mixed Chimerism and Secondary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia |
| Q84021806 | Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia |
| Q52842045 | Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. |
| Q91862397 | No Evidence for Particular Association Between HLA-Haploidentical Hematopoietic Stem Cell Transplantation and Psychological Distress |
| Q96031469 | Nontuberculous mycobacterial bloodstream infections after allogeneic hematopoietic stem cell transplantation |
| Q92382581 | Nutritional risk index as a risk factor for breakthrough candidemia in allogeneic hematopoietic stem cell transplantation |
| Q40791833 | Occurrence of Donor Cell-derived Lymphoid Blast Crisis 24 Years Following Related Bone Marrow Transplantation for Chronic Myeloid Leukemia. |
| Q40926932 | Optic neuritis as an initial manifestation of human herpesvirus 6 reactivation after unrelated bone marrow transplantation. |
| Q84855125 | Osteonecrosis of the humeral head |
| Q39036994 | Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8. |
| Q52721764 | Outcome of patients with acute undifferentiated leukemia after allogeneic hematopoietic stem cell transplantation. |
| Q89777162 | Overexpression of RUNX1 short isoform has an important role in the development of myelodysplastic/myeloproliferative neoplasms |
| Q54462989 | Pneumatosis coli after thalidomide treatment. |
| Q52981533 | Post-transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high-risk acute myeloid leukaemia. |
| Q42231820 | Posttransplantation bone marrow assessment by quantifying hematopoietic cell-derived mRNAs in plasma exosomes/microvesicles |
| Q92996654 | Potential prognostic impact of EBV RNA-seq reads in gastric cancer: a reanalysis of The Cancer Genome Atlas cohort |
| Q100381533 | Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation |
| Q41995146 | Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation |
| Q58555196 | Presacral extramedullary hematopoiesis under treatment with an erythropoietin-stimulating agent for myelodysplasia |
| Q50045627 | Prior harvesting and cryopreservation of peripheral blood stem cells from related donors: current situations in Japan |
| Q49358194 | Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in Japan |
| Q110659596 | Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia |
| Q98223049 | Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCT |
| Q57795857 | Prognostic impact of low allelic ratio ITD and mutation in acute myeloid leukemia |
| Q64952019 | Progressive Hepatic Cirrhosis Early After Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Chronic Hepatitis C Infection |
| Q45035516 | Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies |
| Q40563953 | Pyomyositis as a focus of infection in hematological disorders: a report of 3 cases |
| Q39153137 | Pyomyositis caused by Streptococcus pneumoniae after allogeneic hematopoietic stem cell transplantation |
| Q45376014 | Rapidly progressive Epstein-Barr virus-associated lymphoproliferative disorder unpredictable by weekly viral load monitoring |
| Q58590862 | Reassessment of clinical implication of pretransplant surgical procedures for pulmonary invasive fungal lesions |
| Q44679459 | Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia. |
| Q40371026 | Retrospective analysis of clinical outcomes of the patients with chronic myeloid leukemia who stopped administration of tyrosine kinase inhibitors: a single institution experience. |
| Q53151347 | Risk assessment for acute kidney injury after allogeneic hematopoietic stem cell transplantation based on Acute Kidney Injury Network criteria. |
| Q43146654 | Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase |
| Q98952186 | Safety of total body irradiation using intensity-modulated radiation therapy by helical tomotherapy in allogeneic hematopoietic stem cell transplantation: a prospective pilot study |
| Q44775754 | Salt-wasting nephropathy induced by foscarnet treatment for HHV-6 encephalitis in a hematopoietic stem cell transplant |
| Q84034938 | Second allogeneic transplantation for relapsed acute leukemia after initial allogeneic hematopoietic stem cell transplantation |
| Q37508110 | Severe Hypoxemia in a Healthy Donor for Allogeneic Hematopoietic Stem Cell Transplantation after Only the First Administration of Granulocyte-Colony Stimulating Factor. |
| Q83884615 | Spontaneous huge hematoma in the abdominal wall after lenalidomide |
| Q40752636 | Steroid Pulse Therapy for Blood Cell Recovery in Allogeneic Hematopoietic Stem Cell Transplantation |
| Q93118606 | Successful hematopoietic stem-cell mobilization with plerixafor plus granulocyte-colony stimulating factor in multiple myeloma patients treated with pomalidomide |
| Q77635729 | Successful unrelated bone marrow transplantation after arsenic trioxide treatment in a patient with relapsed acute promyelocytic leukemia |
| Q88623728 | Sudden blindness as an initial manifestation of localized fusariosis in ethmoid sinus and optic nerve |
| Q82948919 | Sustained complete molecular response of chronic myeloid leukemia after discontinuation of second-generation tyrosine kinase inhibitors |
| Q40543416 | Sustained remission of MDS overt leukemia associated with abrupt discontinuation of immunosuppression following relapse after the second course of allogeneic hematopoietic stem cell transplantation |
| Q84876063 | Sustained remission of psoriasis vulgaris after allogeneic bone marrow transplantation |
| Q39933810 | Tandem autologous versus autologous/allogeneic transplantation for multiple myeloma: propensity score analysis. |
| Q93162677 | The Authors' Reply to "The Addition of Prophylactic Antibiotics Can Achieve a Favorable Outcome" |
| Q47743446 | The Efficacy of Reduced-dose Dasatinib as a Subsequent Therapy in Patients with Chronic Myeloid Leukemia in the Chronic Phase: The LD-CML Study of the Kanto CML Study Group. |
| Q40713867 | The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT). |
| Q91761451 | The effect of melphalan dose and total body irradiation as reduced-intensity conditioning for acute lymphoblastic leukemia patients undergoing allogeneic stem cell transplantation |
| Q90668385 | The emergence of rare nocardiosis following allogeneic hematopoietic stem cell transplantation in the era of molecular taxonomy |
| Q42220449 | The predictive value for pulmonary infection by area over the neutrophil curve (D-index) in patients who underwent reduced intensity hematopoietic stem cell transplantation. |
| Q94527686 | The sensitivity of the FLT3-ITD detection method is an important consideration when diagnosing acute myeloid leukemia |
| Q92472937 | Timely Diagnosis and Successful Treatment of Intravascular Large B-Cell Lymphoma in an Elderly Patient with Poor Performance Status |
| Q85316776 | Toxic encephalopathy after exposure to azacitidine |
| Q82310784 | Tyrosine kinase inhibitor therapy for acute myeloid leukemia with late-appearing Philadelphia chromosome |
| Q47570435 | Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 201. |
| Q91574445 | Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemia |
| Q85258603 | Urinary liver-type fatty acid-binding protein linked with increased risk of acute kidney injury after allogeneic stem cell transplantation |
| Q44572145 | Use of octreotide in the management of severe duodenal bleeding after unrelated-donor bone marrow transplantation |
| Q64375471 | [Acute necrotizing tubulointerstitial nephritis due to adenoviral infection following hematopoietic stem cell transplantation: clinical findings obtained from 4 autopsy cases] |
| Q53094326 | [Leukemia: recent progress in diagnosis and treatment. Topics: III. Diagnosis and treatments; 6. Indication and clinical outcome of hematopoietic stem cell transplantation for acute leukemia]. |
| Q80301325 | [Successful treatment with voriconazole for disseminated cutaneous and visceral infection by Fusarium solani in a patient with acute myeloid leukemia] |
| Q91864245 | [Transfusion-associated circulatory overload with pulmonary alveolar hemorrhage following allogeneic bone marrow transplantation] |
| Q89549415 | [Tyrosine kinase inhibitor maintenance therapy following allogenic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia] |
| Q104142095 | [Vacuolar myelopathy after allogeneic bone marrow transplantation in a patient with acute lymphoblastic leukemia] |
Search more.